Quantitative Pneumocystis jirovecii real-time PCR to differentiate disease from colonisation

Pathology. 2021 Dec;53(7):896-901. doi: 10.1016/j.pathol.2021.03.006. Epub 2021 Jul 1.

Abstract

We studied a Pneumocystis jirovecii quantitative polymerase chain reaction (qPCR) for distinguishing P. jirovecii disease from colonisation. Eighty-two respiratory samples from 65 patients with qPCR results were analysed against a gold standard clinical diagnosis of Pneumocystis pneumonia. High inter-assay reproducibility using recombinant and clinical material was observed. Contemporaneous samples from the same patient displayed high variability (median difference 2.6 log10 copies/mL, IQR 2.1-3.1 log10 copies/mL). Despite this, area under the receiver operator characteristic curve was 0.8. An optimum cut-off of 2.8 log10 copies/mL (equivalent to CT of 34.0 cycles) had 59% sensitivity and 92% specificity. The median P. jirovecii load was 7.3 log10 copies/mL in HIV patients compared to 2.6 log10 copies/mL in non-HIV patients. Specificity was 100% in non-HIV patients with qPCR of >3.8 log10 copies/mL. qPCR was useful for distinguishing P. jirovecii disease from colonisation. A quantitative standard, standardisation of definitions and methods are required to improve the generalisability of results.

Keywords: Pneumocystis jirovecii; quantitative methods; real-time PCR.

MeSH terms

  • Aged
  • Asymptomatic Infections
  • Female
  • HIV Infections / complications*
  • Humans
  • Male
  • Middle Aged
  • Pneumocystis Infections / complications
  • Pneumocystis Infections / diagnosis*
  • Pneumocystis Infections / microbiology
  • Pneumocystis carinii / genetics
  • Pneumocystis carinii / isolation & purification*
  • Pneumonia, Pneumocystis / complications
  • Pneumonia, Pneumocystis / diagnosis*
  • Pneumonia, Pneumocystis / microbiology
  • Real-Time Polymerase Chain Reaction / standards*
  • Reproducibility of Results
  • Sensitivity and Specificity